Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing Platform

QSI Stock  USD 1.14  0.09  7.32%   
Under 57% of QuantumSi's investor base is looking to short. The analysis of the overall investor sentiment regarding QuantumSi suggests that many traders are alarmed. QuantumSi's investing sentiment shows overall attitude of investors towards QuantumSi.
  
Quantum-Si Incorporated , The Protein Sequencing Company, today announced the launch of new platf

Read at businesswire.com
businesswire News
  

QuantumSi Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards QuantumSi can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

QuantumSi Fundamental Analysis

We analyze QuantumSi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QuantumSi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QuantumSi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Market Capitalization

Market Capitalization Comparative Analysis

QuantumSi is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.

QuantumSi Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with QuantumSi stock to make a market-neutral strategy. Peer analysis of QuantumSi could also be used in its relative valuation, which is a method of valuing QuantumSi by comparing valuation metrics with similar companies.

Peers

QuantumSi Related Equities

CRBUCaribou Biosciences   8.91   
0%
80.0%
VERVVerve Therapeutics   8.85   
0%
79.0%
HOOKHookipa Pharma   6.90   
0%
62.0%
HRTXHeron Therapeuti   5.45   
0%
49.0%
BEAMBeam Therapeutics   5.26   
0%
47.0%
BDTXBlack Diamond   4.05   
0%
36.0%
NTLAIntellia Therapeutics   3.26   
0%
29.0%
CRSPCrispr Therapeutics   3.10   
0%
27.0%
ABOSAcumen Pharmaceuticals   2.73   
0%
24.0%
SEERSeer   0.81   
0%
7.0%
EDITEditas Medicine   0.45   
4.0%
0%
ALECAlector   0.78   
7.0%
0%
RNAAvidity Biosciences   1.07   
9.0%
0%
PRMEPrime Medicine,   1.20   
10.0%
0%
NRIXNurix Therapeutics   2.57   
23.0%
0%
MNOVMediciNova   3.37   
30.0%
0%
HCWBHCW Biologics   10.34   
92.0%
0%
PASGPassage Bio   11.12   
100.0%
0%

Complementary Tools for QuantumSi Stock analysis

When running QuantumSi's price analysis, check to measure QuantumSi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuantumSi is operating at the current time. Most of QuantumSi's value examination focuses on studying past and present price action to predict the probability of QuantumSi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuantumSi's price. Additionally, you may evaluate how the addition of QuantumSi to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments